Kirsten has over 20 years of experience in stroke with various leadership roles at Boston Scientific, Stryker, and Imperative Care. She was the Founder and Chief Executive Officer of Kandu Health and became the Chief Marketing Officer and General Manager of Clinical Services at the conclusion of the merger with Neurolutions in March 2025. Kirsten holds several patents in the fields of stroke treatment and detection, and she is the author of several peer-reviewed papers in the field of stroke and access to care.
